BIO

Bio-Rad Laboratories, Inc.Class A (BIO)

NYSE: BIOUSD
279.99 USD
+4.57 (+1.66%)
AT CLOSE (11:59 AM EDT)
279.88
-0.11 (-0.04%)
POST MARKET (AS OF 07:45 PM EDT)
🔴Market: CLOSED
Open?$275.31
High?$284.45
Low?$274.08
Prev. Close?$279.99
Volume?253.7K
Avg. Volume?301.9K
VWAP?$278.63
Rel. Volume?0.84x
Bid / Ask
Bid?$270.37 × 40
Ask?$288.25 × 40
Spread?$17.88
Midpoint?$279.31
Valuation & Ratios
Market Cap?7.6B
Shares Out?21.9M
Float?18.7M
Float %?85.3%
P/E Ratio?9.94
P/B Ratio?1.01
EPS?$28.15
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.62Strong
Quick Ratio?4.19Strong
Cash Ratio?1.02Strong
Debt/Equity?0.16Low
ValuationFAIRLY VALUED
Score
78/100
P/E?
9.9CHEAP
P/B?
1.01CHEAP
P/S?
2.93CHEAP
P/FCF?
20.2FAIR
EV/EBITDA?
37.4HIGH
EV/Sales?
3.19FAIR
Returns & Efficiency
ROE?
10.2%FAIR
ROA?
7.2%STRONG
Cash Flow & Enterprise
FCF?$374.6M
Enterprise Value?$8.2B
Related Companies
Loading...
News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
7.6B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1980-02-29
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000